期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (2)
Systemic mastocytosis is a rare disease which is being better recognized and managed. While the vast majority of patients have indolent disease with v......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (3)
Throughout the Coronavirus Disease 2019 (COVID-19) pandemic, understanding the effects of COVID-19 on persons with Sickle Cell Disease (SCD) and Sickl......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (2)
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm with a very heterogenous clinical course. Median survival of patients with overt MF is clo......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (3)
Coronavirus Disease 2019 (COVID-19) has been widely associated with increased thrombotic risk, with many different proposed mechanisms. One such mecha......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (4)
Autologous T cells genetically modified with a CD19 chimeric antigen receptor are an effective therapy for children and adults with relapsed or refrac......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (1)
The etiology of pediatric cancer associated thrombosis (CAT) is multifactorial and may reflect pro-coagulant alterations of the hemostatic system indu......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (2)
Pre-Fibrotic Myelofibrosis is a frequently under-recognised entity that has distinct features separate to those of both Essential Thrombocythaemia and......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (3)
Severe acute respiratory disease coronavirus 2 (SARS-COV-2) first emerged in Wuhan, China, in December 2019 and has caused a global pandemic of a scal......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (4)
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative approach for patients with acute myeloid leukemia (AML), relapse......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (3)
Antiphospholipid syndrome and the coagulopathy of COVID-19 share many pathophysiologic features, including endotheliopathy, hypercoagulability, and ac......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (3)
The SARS-CoV-2 virus has complex and divergent immune alterations in differing hosts and over disease evolution. Much of the nuanced COVID-19 disease ......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (1)
Patients with pancreatic cancer have a very high risk of both venous and arterial thrombosis compared with other cancers, caused by a tumour-driven hy......
期刊： BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022; 35 (4)
The safe diminution of leukemic cell numbers to a level such that the patient will not succumb to their disease has been an achievable, yet often elus......
